Related Experiment Videos
[Cardiac decompensation, renal function and non-steroidal anti-inflammatory agents]
1Service de Néphrologie et Hypertension artérielle, CHU Sart Tilman.
Revue Medicale De Liege
|November 21, 2002
Summary
New coxib-inhibitor drugs pose similar renal and cardiac risks as traditional non-steroidal anti-inflammatory drugs. Elderly patients with cardiovascular history, heart failure, or liver/kidney issues face heightened risks during treatment.
Area of Science:
- Pharmacology
- Cardiology
- Nephrology
Context:
- A case report highlighted heart failure in an elderly patient treated with coxib-inhibitors.
- This prompted a review of associated risks.
Purpose:
- To emphasize the potential for renal and cardiac complications with coxib-inhibitors.
- To compare these risks with non-specific anti-inflammatory drugs.
Summary:
- Coxib-inhibitors, like non-specific anti-inflammatory drugs, carry risks of acute renal failure and cardiac complications.
- Specific risk factors include old age, pre-existing heart failure, liver insufficiency, nephrotic syndrome, and concurrent use of diuretics or ACE inhibitors.
Impact:
- Clinicians should exercise caution when prescribing coxib-inhibitors, especially in high-risk populations.
- Awareness of these risks is crucial for preventing adverse cardiovascular and renal events.